share_log

UroGen Pharma Ltd | 424B4: Prospectus

SEC ·  Jan 22, 2018 16:07
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more